ISCHEMIC HEART DISEASE AND FAMILIAL HYPERCHOLESTEROLEMIA: ABOUT THE VIOLATION OF BIOGENIC AMINES METABOLISM
Keywords:
Sympathetic-Adrenal System, Hypercholesterolemia, Fluorimetric MethodAbstract
The effectiveness of the fight against IHD depends primarily on preventive measures at the early stages, on the elimination or reduction of known factors of IHD
References
Bittner V. Familial hypercholesterolemia-epidemiology, diagnosis and screening. Curr Atheroscler Rep. 2015. No. 17(2). p. 482. DOI: 10.1007/s11883-014 - 0482-5.
Michael D. S., Sergio F. I look under the hood. Clinical Journal Lipidology. 2018. No. 5. p. 3- DOI: 10.1016/j. jacl. 2018. 05. 020
Meshkov A. N., Stambolsky A.V., Nikitina L. N., etc. Genetic risk factors for coronary heart disease in patients with familial hypercholesterolemia. Cardiology 2005; 7: 10-15.
Keys Hoving G., Davidson M. H., Kastelein J. P., O'Conor A.M. Diagnosis and treatment treatment of familial hypercholesterolemia. European Journal of Cardiology, 2013, no. 34. P. 962-971. DOI: 10.1093 / eurheartj/eht015.
Ezhov M. V., Bliznyuk S. A. Register of patients with familial hypercholesterolemia and patients of very high cardiovascular risk with insufficient effectiveness of the conducted lipid-lowering therapy (RENAISSANCE) Eurasian Journal of Cardiology. 2019; No. 24-5, pp. 7-13.
Schwartz J., Padmanabhan A. Akvi N., Balogun R. A., Delaney M., Dunbar N. M., Witt V., Wu Yu., Schatz B. H. methodological recommendations for the use of therapeutic apheresis in Clinical practice-evidence-based approach to writing American society for apheresis: the Seventh special issue. J. Apher Wedge. 2016 June; 31(3): 149-62. Dpi: 10.1002/SKA. 21470.
Keys Hoving G., Davidson M. H., Kastelein J. P., O'Conor A.M. Diagnosis and treatment of familial hypercholesterolemia. European Journal of Cardiology, 2013, no. 34. P. 962-971. DOI: 10.1093 / eurheartj/eht 015.
Lankin V. Z., Vikhert A.M., Tikhaze A. K. Free radical processes in the diseases of the cardiovascular system. Cardiology 2000; 7: 48-61
Sabatine MS, Giuliano RP, Kich AC, et al. Evolocumab and clinical results in patients with cardiovascular diseases. N Engl J Med. 2017;376 (18):1713-22. doi:10.1056/ NEJMoa1615664.
Singh S., Bittner V. Familial hypercholesterolemia-epidemiology, diagnosis and screening. Curr Atheroscleroz Rep. 2015. No. 17(2). p. 482. DOI: 10.1007/s11883-014 - 0482-5.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
